Calvin Blissett on X
$ADMA Profitable small cheap biotech with 3 FDA approvals accelerated stock repurchase plan https://t.co/jVbFVNKBA5
NASDAQ
Adma Biologics, INC.
ADMA
2 stories
$2.3B Market cap · 2026-10-08
Idea Brunch on X
Idea Brunch with Chris Hammond of @JaguarCapMgmt A masterclass in healthcare investing. Tickers mentioned: $DRIO, $ADMA, and $QDEL https://t.co/l1BHGMZkRG
Investor Letters
Letters that discuss ADMA.
- Royce Investment Partners Royce Small-Cap Fund Manager Commentary year-to-date period ended 6/30/26 ACA $7.2BADMA $2.3BESI $9B
Tickers on this page
Companies the stories above are also about, besides ADMA.
